OcuSciences is a medical device company developing a rapid, unique and patented non-invasive ocular imaging technique called flavoprotein fluorescence (FPF). FPF is being developed to detect retinal diseases, such as diabetic retinopathy, macular degeneration, and glaucoma, earlier than current clinical methods and before irreversible cell death becomes visible. The first device, the OcuMet Beacon, is currently being developed and validated at several top ophthalmic centers.
Location: United States, Michigan, Ann Arbor
Member count: 1-10
Founded date: 2008